Drawing for ALBIX

USPTO serial 88712453

ALBIX

Reviewed by CopyMark Law Group

Reg. 6254467Status 700Renewal
Filing date
Status date
Registration date
Jan 26, 2021
Examiner
SINGH, TEJBIR
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ALBIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen Lim

Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
001Albumin for industrial purposes used for preparation of pharmaceuticals; reagents and diagnostic reagents for scientific and research use; protein for industrial useACTIVE—
005Pharmaceutical products and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; reagents and diagnostic reagents for medical use; protein supplements; albuminous preparations for pharmaceutical and medical purposes; recombinant albumin preparations for pharmaceutical and medical purposes; diagnostic radiopharmaceutical agent for use in PET imagingACTIVE—
042Scientific and product research and development services; consultancy services in the field of scientific and product research and development servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 26, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 16, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 16, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 16, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 16, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 7, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 7, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 7, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Apr 7, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 7, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 7, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 26, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 10, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 10, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 21, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 8, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 8, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 3, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 3, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2020DOCKASSIGNED TO EXAMINER—
Jan 23, 2020AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jan 22, 2020ALIEASSIGNED TO LIE—
Jan 13, 2020PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 7, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 5, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance